|
1
|
Jones PA and Laird PW: Cancer epigenetics
comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: a fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esteller M: Dormant hypermethylated tumour
suppressor genes: questions and answers. J Pathol. 205:172–180.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karpf AR and Jones DA: Reactivating the
expression of methylation silenced genes in human cancer. Oncogene.
21:5496–5503. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamashita K, Upadhyay S, Osada M, et al:
Pharmacologic unmasking of epigenetically silenced tumor suppressor
genes in esophageal squamous cell carcinoma. Cancer Cell.
2:485–495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suzuki H, Gabrielson E, Chen W, et al: A
genomic screen for genes upregulated by demethylation and histone
deacetylase inhibition in human colorectal cancer. Nat Genet.
31:141–149. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koul S, Houldsworth J, Mansukhani MM, et
al: Characteristic promoter hypermethylation signatures in male
germ cell tumors. Mol Cancer. 1:82002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Konduri SD, Srivenugopal KS, Yanamandra N,
et al: Promoter methylation and silencing of the tissue factor
pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor
of matrix metalloproteinases in human glioma cells. Oncogene.
22:4509–4516. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Knobbe CB, Reifenberger J, Blaschke B and
Reifenberger G: Hypermethylation and transcriptional downregulation
of the carboxyl-terminal modulator protein gene in glioblastomas. J
Natl Cancer Inst. 96:483–486. 2004. View Article : Google Scholar
|
|
10
|
Sawa H, Murakami H, Ohshima Y, et al:
Histone deacetylase inhibitors such as sodium butyrate and
trichostatin A inhibit vascular endothelial growth factor
(VEGF) secretion from human glioblastoma cells. Brain Tumor
Pathol. 19:77–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schuebel KE, Chen W, Cope L, et al:
Comparing the DNA hypermethylome with gene mutations in human
colorectal cancer. PLoS Genet. 3:1709–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishiguro M, Iida S, Uetake H, et al:
Effect of combined therapy with low-dose 5-aza-2′-deoxycytidine and
irinotecan on colon cancer cell line HCT-15. Ann Surg Oncol.
14:1752–1762. 2007.
|
|
13
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu W, Zhou B, Zou H, et al:
Hypermethylation of growth arrest DNA damage-inducible gene 45 beta
promoter in human hepatocellular carcinoma. Am J Pathol.
165:1689–1699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ko JM, Chan PL, Yau WL, et al:
Monochromosome transfer and microarray analysis identify a critical
tumor-suppressive region mapping to chromosome 13q14 and
THSD1 in esophageal carcinoma. Mol Cancer Res. 6:592–603.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mori Y, Yin J, Sato F, et al:
Identification of genes uniquely involved in frequent
microsatellite instability colon carcinogenesis by expression
profiling combined with epigenetic scanning. Cancer Res.
64:2434–2438. 2004. View Article : Google Scholar
|
|
17
|
Khamas A, Ishikawa T, Shimokawa K, et al:
Screening for epigenetically masked genes in colorectal cancer
using 5-aza-2′-deoxycytidine, microarray and gene expression
profile. Cancer Genomics Proteomics. 9:67–75. 2012.PubMed/NCBI
|
|
18
|
Liang G, Gonzales FA, Jones PA, Orntoft TF
and Thykjaer T: Analysis of gene induction in human fibroblasts and
bladder cancer cells exposed to the methylation inhibitor
5-aza-2′-deoxycytidine. Cancer Res. 62:961–966. 2002.PubMed/NCBI
|
|
19
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
20
|
Ali D: Identification of novel epigenetic
biomarkers in colorectal cancer, GLDC and PPP1R14A.
Department of Molecular Biosciences (IMBV), Faculty of Mathematics
and Natural Sciences, University of Oslo; pp. 972010
|
|
21
|
Easwaran HP, van Neste L, Cope L, et al:
Aberrant silencing of cancer-related genes by CpG hypermethylation
occurs independently of their spatial organization in the nucleus.
Cancer Res. 70:8015–8024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim MS, Lee J and Sidransky D: DNA
methylation markers in colorectal cancer. Cancer Metastasis Rev.
29:181–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu L and Jain RK: Down-regulation of
placenta growth factor by promoter hypermethylation in human lung
and colon carcinoma. Mol Cancer Res. 5:873–880. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gardiner-Garden M and Frommer M: CpG
islands in vertebrate genomes. J Mol Biol. 196:261–282. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takai D and Jones PA: The CpG island
searcher: a new WWW resource. In Silico Biol. 3:235–240.
2003.PubMed/NCBI
|
|
26
|
Karolchik D, Hinrichs AS, Furey TS, et al:
The UCSC table browser data retrieval tool. Nucleic Acids Res.
32:D493–D496. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lind GE, Thorstensen L, Løvig T, et al: A
CpG island hypermethylation profile of primary colorectal
carcinomas and colon cancer cell lines. Mol Cancer. 3:282004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X and Lawler J: Thrombospondin-based
antiangiogenic therapy. Microvasc Res. 74:90–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rojas A, Meherem S, Kim YH, et al: The
aberrant methylation of TSP1 suppresses TGF-beta1 activation
in colorectal cancer. Int J Cancer. 123:14–21. 2008.
|
|
30
|
Moncada-Pazos A, Obaya AJ, Fraga MF, et
al: The ADAMTS12 metalloprotease gene is epigenetically
silenced in tumor cells and transcriptionally activated in the
stroma during progression of colon cancer. J Cell Sci.
122:2906–2913. 2009.
|
|
31
|
Lai PS, Cheah PY, Kadam P, et al:
Overexpression of RB1 transcript is significantly correlated
with 13q14 allelic imbalance in colorectal carcinomas. Int J
Cancer. 119:1061–1066. 2006.PubMed/NCBI
|
|
32
|
Derks S, Postma C, Carvalho B, et al:
Integrated analysis of chromosomal, microsatellite and epigenetic
instability in colorectal cancer identifies specific associations
between promoter methylation of pivotal tumour suppressor and DNA
repair genes and specific chromosomal alterations. Carcinogenesis.
29:434–439. 2008. View Article : Google Scholar
|
|
33
|
Kis E, Szatmári T, Keszei M, et al:
Microarray analysis of radiation response genes in primary human
fibroblasts. Int J Radiat Oncol Biol Phys. 66:1506–1514. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kazerounian S, Yee KO and Lawler J:
Thrombospondins in cancer. Cell Mol Life Sci. 65:700–712. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lagerstedt KK, Kristiansson E, Lönnroth C,
et al: Genes with relevance for early to late progression of colon
carcinoma based on combined genomic and transcriptomic information
from the same patients. Cancer Inform. 9:79–91. 2010.PubMed/NCBI
|
|
36
|
Cretu A, Sha X, Tront J, Hoffman B and
Liebermann DA: Stress sensor Gadd45 genes as therapeutic targets in
cancer. Cancer Ther. 7:268–276. 2009.PubMed/NCBI
|
|
37
|
Ying J, Srivastava G, Hsieh WS, et al: The
stress-responsive gene GADD45G is a functional tumor
suppressor, with its response to environmental stresses frequently
disrupted epigenetically in multiple tumors. Clin Cancer Res.
11:6442–6449. 2005.
|
|
38
|
Ju S, Zhu Y, Liu L, et al: Gadd45b and
Gadd45g are important for anti-tumor immune responses. Eur J
Immunol. 39:3010–3018. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Na YK, Lee SM, Hong HS, Kim JB, Park JY
and Kim DS: Hypermethylation of growth arrest DNA-damage-inducible
gene 45 in non-small cell lung cancer and its relationship with
clinicopathologic features. Mol Cells. 30:89–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
